secwatch / observer
8-K filed May 28, 2026, 5:15 PM ET ticker DXCM CIK 0001093557
other material confidence high sentiment neutral materiality 0.15

DexCom announces results of 2026 Annual Meeting, all proposals approved by stockholders

DEXCOM INC

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

DEXCOM INC shareholders approved Election of Directors at the 2026-05-27 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-27
Exact text from the filing
Dexcom stockholders elected the following twelve nominees to the Company’s board of directors
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

DEXCOM INC shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-27 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-27
Exact text from the filing
Dexcom stockholders ratified the selection by the audit committee of the board of directors of Deloitte & Touche LLP as Dexcom’s independent registered public accounting firm
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

DEXCOM INC shareholders approved Advisory Vote to Approve Named Executive Officer Compensation at the 2026-05-27 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-05-27
Exact text from the filing
Dexcom stockholders approved, on a non-binding advisory basis, the compensation of Dexcom’s named executive officers
View on SEC.gov

72 shareholder votes filed in the last 30 days. Browse all shareholder votes →

DEXCOM INC filing history →

Source: SEC EDGAR
accession 0001093557-26-000105
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.